secwatch / observer
8-K filed Sep 30, 2025 23:59 UTC CIK 0001633932
other_material confidence high sentiment neutral materiality 0.50

ESSA Pharma receives amended interim order approving Oct 3 special meeting for Xeno merger

ESSA Pharma Inc.

item 8.01item 9.01
Source: SEC EDGAR
accession 0001104659-25-095056

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.